Expertise in
4
conditions

Shirong K. Zhang

Key Laboratory Of Clinical Cancer Pharmacology And Toxicology Research Of Zhejiang Province, Key Laboratory Of Clinical Cancer Pharmacology And Toxicology Research Of Zhejiang Province Hangzhou, 
Hangzhou, CN 
Expertise in
4
conditions
Key Laboratory Of Clinical Cancer Pharmacology And Toxicology Research Of Zhejiang Province, Key Laboratory Of Clinical Cancer Pharmacology And Toxicology Research Of Zhejiang Province Hangzhou, 
Hangzhou, CN 

Overview

Shirong Zhang practices practicing medicine in Hangzhou, China.

Zhang is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Metastatic Insulinoma, and Tissue Biopsy.

They are actively involved in clinical research, co-authoring 89 peer reviewed articles.

Locations

Key Laboratory Of Clinical Cancer Pharmacology And Toxicology Research Of Zhejiang Province, Key Laboratory Of Clinical Cancer Pharmacology And Toxicology Research Of Zhejiang Province Hangzhou, Hangzhou, 310006, China
Other Locations
Weihai, 264200, China
Nanjing, 210029, China
Shanghai, 200032, China
Jinan, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

89 Total Publications

Cyclofenil blocks the secretion of IL-1β by inhibiting assembly of the NLRP3 inflammasome independent of estrogen receptor.
Cyclofenil blocks the secretion of IL-1β by inhibiting assembly of the NLRP3 inflammasome independent of estrogen receptor.
Journal: Molecular biology reports
Published: May 18, 2026

Frequently Asked Questions about Shirong K. Zhang

Is Shirong K. Zhang a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Shirong K. Zhang is classified as an Advanced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shirong K. Zhang participate in research or clinical trials?

Yes. Shirong K. Zhang has published 89 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Shirong K. Zhang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhang's expertise for a condition
ConditionClose
      View All 21 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile